Cromwell Holdings’s AstraZeneca AZN Stock Holding History

Cromwell Holdings’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$580K	Hold	3,059	–	–	0.26%	66
2026 Q1	$603K	Sell	3,059 -1	-0%	-$193	0.34%	53
2025 Q4	$563K	Hold	3,060	–	–	0.31%	53
2025 Q3	$469K	Hold	3,060	–	–	0.25%	70
2025 Q2	$428K	Hold	3,060	–	–	0.26%	73
2025 Q1	$450K	Hold	3,060	–	–	0.29%	70
2024 Q4	$401K	Hold	3,060	–	–	0.23%	80
2024 Q3	$477K	Hold	3,060	–	–	0.31%	65
2024 Q2	$477K	Buy	+3,060	New	+$460K	0.29%	60

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Cromwell Holdings's AZN Position: Q2 2026 in Review

Cromwell Holdings held its AstraZeneca (AZN) position steady in Q2 2026 at 3,059 shares worth $580K. The position accounts for 0.26% of the portfolio, ranked #66.

Cromwell Holdings first reported a position in AZN in Q2 2024 and has held it in 9 quarters since. The position peaked at $603K in Q1 2026. 399 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Cromwell Holdings held 3,059 shares of AstraZeneca worth $580K as of Q2 2026.
Cromwell Holdings left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.26% of Cromwell Holdings's portfolio in Q2 2026, its #66 holding.
Cromwell Holdings first reported a position in AstraZeneca in Q2 2024 and has held it in 9 quarters since.
Cromwell Holdings's AstraZeneca position peaked at $603K in Q1 2026.
399 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.